Guatemala vs Mozambique: Antiretroviral therapy coverage for PMTCT
Guatemala
82.0%
in 2023
Mozambique
82.0%
in 2024
Guatemala rank
38th
Mozambique rank
38th
Antiretroviral therapy coverage for PMTCT over time
- Guatemala
- Mozambique
How they compare
Guatemala currently reports 82.0% against 82.0% in Mozambique, a difference of 0.0%.
The two have swapped places 5 times across 24 shared years of data; in 2000 it was Guatemala ahead.
Guatemala ranks 38th and Mozambique ranks 38th of 84 countries.
Across the 3 decades both report, Guatemala averaged higher in 1 and Mozambique in 2.
Head to head by decade
| Decade | Guatemala | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.8% | 18.0% | 5.8% | Guatemala |
| 2010s | 54.3% | 65.8% | 11.5% | Mozambique |
| 2020s | 75.0% | 80.8% | 5.8% | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Guatemala or Mozambique?
- Guatemala, at 82.0% against 82.0% in Mozambique as of 2023.
- What is the difference in antiretroviral therapy coverage for pmtct between Guatemala and Mozambique?
- 0.0%, with Guatemala ahead.
- How many years of comparable data are there for Guatemala and Mozambique?
- 24 years are reported by both, from 2000 to 2023.
- How do Guatemala and Mozambique rank globally for antiretroviral therapy coverage for pmtct?
- Guatemala ranks 38th and Mozambique ranks 38th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).